From antibody-drug conjugates to PARP inhibitors, innovative treatments are offering new hope for patients with ...

Roche's Itovebi combo gains EMA panel endorsement for advanced breast cancer with PIK3CA mutation. Read more here.

Roche’s plan to bolster Tecentriq’s position in small cell lung cancer with Jazz Pharmaceuticals’ Zepzelca has paid off. | ...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 27 years, gives his take on the ASX healthcare sector for the week and his ‘Powerplay’ stock ...

Maltese researchers are studying ways to reduce the heart-related side effects of some anti-cancer therapies. They are studying a new drug combination in the lab, using what are often referred to ...

"The drug also affects a transcription factor called NUPR1, which is linked to treatment resistance in GBM and other cancers like pancreatic cancer. By targeting this pathway, TFP may help make ...

Anti-EGFR therapies ... gel with no active drug. According to the scientists, it is now possible to alleviate skin toxicity without compromising the effectiveness of cancer treatment.

The upshot is that far greater levels of anti-cancer metabolites are generated and activated inside tumor cells. This enhanced form of Cordycepin was dubbed NUC-7738. This novel chemotherapy drug ...

The answer is a qualified "yes." Attempts to develop in vitro systems for predicting the in vivo effectiveness of anti-cancer drugs extend back to the start of the modern era of chemotherapy in ...

These trials saw patients randomly assigned ibrutinib, a targeted cancer drug, either alone or in combination with other anti-cancer drugs, or to a drug regimen that did not include ibrutinib.

Sanofi had been assessing a CD123-targeting drug ... SAR’514 in multiple myeloma. But the company said Wednesday morning that it will now terminate a phase 1/2 study in this cancer indication ...

The free cancer treatment programme was launched in Hayatabad Medical Complex (HMC) Peshawar in 2013, where about 10,000 patients have received cashless drugs as ... to procure anti-cancer ...